The global Veterinary Antimicrobial Susceptibility Testing Market is projected to reach USD 61.76 billion by 2032, growing at a CAGR of 5.10% during the forecast period. The market's growth is driven by factors such as the increasing incidence of infectious diseases in animals and the demand for accurate and reliable veterinary antimicrobial susceptibility testing.

The increasing desire for livestock and pets stands as a prominent factor propelling market expansion. The heightened appetite for meat and dairy items has resulted in a surge in livestock farming, consequently elevating the potential for infectious diseases among animals. The pivotal role of veterinary antimicrobial susceptibility testing lies in safeguarding the quality of animal goods and curbing the transmission of diseases.

Get a free sample PDF of the report, visit @ https://www.reportsanddata.com/download-free-sample/6423

The global veterinary antimicrobial susceptibility testing market is moderately fragmented, with several established players holding a majority of the market share. These companies employ strategies such as partnerships, collaborations, mergers and acquisitions, and new product launches to gain a competitive advantage.

Key players in the Veterinary Antimicrobial Susceptibility Testing Market:

• Thermo Fisher Scientific, Inc.
• BIOTECON Diagnostics GmbH
• Neogen Corporation
• Merck KGaA
• Danaher Corporation
• Becton, Dickinson and Company
• Zoetis Inc.
• Bio-Rad Laboratories, Inc.
• Creative Diagnostics
• Qiagen N.V.
• Accelerate Diagnostics, Inc.

The demand for veterinary antimicrobial susceptibility testing is also fueled by the growing awareness of responsible antimicrobial use in veterinary care. Overuse and improper use of antimicrobial agents in animal health can lead to antimicrobial resistance, which has significant implications for both animal and human health. Stringent regulations have been enacted to address this issue, driving the demand for veterinary antibiotic susceptibility testing.

Additionally, the market is expanding due to the rising adoption of companion animals and the growth of the pet insurance sector. Companion animal owners value the health and well-being of their pets and seek accurate diagnosis and treatment of infectious diseases, leading to increased demand for veterinary antimicrobial susceptibility testing.

To know more about the latest insights of the report, visit @

https://www.reportsanddata.com/request-latest-insight/6423

Factors such as the increasing prevalence of antibiotic resistance, growing demand for animal-derived foods, and the significance of accurate diagnosis and treatment of animal diseases are also contributing to market growth. Furthermore, the development of advanced testing technologies, including automated susceptibility testing systems and point-of-care testing devices, presents new opportunities for revenue growth.

The market's growth is expected to be further supported by the use of digital technologies such as telemedicine and cloud-based data management. These technologies enable real-time collaboration among veterinarians and provide remote monitoring and management of animal health.

However, the high cost of veterinary antimicrobial susceptibility testing and the shortage of qualified veterinary medical professionals are expected to hinder market growth. The absence of standardized testing procedures and the availability of alternative diagnostic techniques may also impede revenue growth.

The global veterinary antimicrobial susceptibility testing market is segmented based on product type and animal type. Type 1 products, which assess the susceptibility of bacteria, fungi, and viruses to antimicrobial drugs, are expected to account for the largest revenue share. Type 2 products, offering faster and more effective testing, are projected to register the highest revenue CAGR. Type 3 products, designed for specialist applications such as food and environmental testing, are expected to experience steady revenue growth.

In terms of animal type, the companion animals segment is anticipated to hold the largest revenue share. The increasing number of pet owners globally drives the demand for veterinary care services, including antimicrobial susceptibility testing. The livestock animals segment is expected to exhibit the highest revenue CAGR due to the growing interest in animal health and welfare in response to the demand for food products derived from animals.

The regional analysis shows that North America is expected to dominate the market, driven by the prevalence of animal diseases and the awareness of animal health among pet owners. Europe is projected to experience the highest revenue CAGR, with rising pet adoption rates and zoonotic disease incidence driving market growth. The Asia Pacific region is expected to grow rapidly, fueled by increasing animal disease prevalence and demand for animal-derived food products. Latin America and the Middle East and Africa are also expected to witness significant revenue growth due to the emphasis on animal health and welfare.

Request a customized copy of the report @ https://www.reportsanddata.com/request-customization-form/6423

Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.  

Browse for more reports:

About Reports and Data 

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

(Head of Business Development)

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports

Browse More Latest Reports @ https://www.reportsanddata.com/report